Lepidext Overview

  • Founded
  • 2015
Founded
  • Status
  • Private
  • Employees
  • 2
Employees
  • Latest Deal Type
  • Angel
  • Investors
  • 8

Lepidext General Information

Description

Developer of pest control technology intended to reduce and eliminate the need for genetically modified plants and chemical pesticides. The company's technology creates biopesticides that are safe, effective, species-specific, and easy to use, and manages the populations of the corn earworm and other destructive bacteria, enabling farmers to improve the way key lepidopteran insect pests are controlled.

Contact Information

Website
www.lepidext.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Agricultural Chemicals
Primary Office
  • 1122 Oak Hill Drive
  • Suite 150
  • Lexington, KY 40505
  • United States
+1 (859) 000-0000

Lepidext Timeline

2019202020212022
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Lepidext Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Angel (individual) 01-Aug-2021 00000 Completed Clinical Trials - General
4. Accelerator/Incubator 00000 Completed Clinical Trials - General
3. Seed Round 19-May-2020 00000 00000 00.000 Completed Clinical Trials - General
2. Accelerator/Incubator 24-Jul-2019 Completed Clinical Trials - General
1. Grant 01-Mar-2019 $100K Completed Clinical Trials - General
To view Lepidext’s complete valuation and funding history, request access »

Lepidext Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Seed 000,000 00.000000 00 00 00 00 00.00
To view Lepidext’s complete cap table history, request access »

Lepidext Executive Team (3)

Name Title Board Seat Contact Info
Bruce Webb Ph.D Co-Founder, Co-Owner, President & Board Member
Angelika Fath-Goodin Ph.D Co-Founder, Operations Executive & Board Member
You’re viewing 2 of 3 executive team members. Get the full list »

Lepidext Board Members (4)

Name Representing Role Since
Angelika Fath-Goodin Ph.D Self Co-Founder, Operations Executive & Board Member 000 0000
Bruce Webb Ph.D Self Co-Founder, Co-Owner, President & Board Member 000 0000
Gary Cullen JD Self Board Member & Advisor 000 0000
Paul Mulhollem Self Board Member & Advisor 000 0000
To view Lepidext’s complete board members history, request access »

Lepidext Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Lepidext Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Bluegrass Angels Angel Group Minority 000 0000 000000 0
Ag Ventures Alliance Venture Capital Minority 000 0000 000000 0
Cultivation Capital Venture Capital Minority 000 0000 000000 0
Innova Memphis Venture Capital Minority 000 0000 000000 0
Ag Innovation Development Group Accelerator/Incubator Minority 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »

Ready to get started?

Request a free trial